Immunic, inc. to announce financial results for the year ended december 31, 2023, and provide corporate update

– webcast to be held at 8:00 am et on february 22, 2024 – new york , feb. 15, 2024 /prnewswire/ --  immunic, inc.  (nasdaq: imux), a biotechnology company developing a clinical pipeline of orally administered, small molecule therapies for chronic inflammatory and autoimmune diseases, today announced that the company will release its financial results for the fourth quarter and year ended december 31, 2023, including a corporate update, on thursday, february 22, 2024, before the opening of the u.s. financial markets. a webcast will follow at 8:00 am et.
IMUX Ratings Summary
IMUX Quant Ranking